RD tests for BB
RD tests for BB
  • Home
  • 3D BioSol™
  • Platforms
    • Obesity
    • Cardiotoxicity
    • Pulmonary Hypertension
    • Platforms' TRLs
  • Products & Services
    • Adipose Tissue
    • Services
  • About Us
  • More
    • Home
    • 3D BioSol™
    • Platforms
      • Obesity
      • Cardiotoxicity
      • Pulmonary Hypertension
      • Platforms' TRLs
    • Products & Services
      • Adipose Tissue
      • Services
    • About Us

  • Home
  • 3D BioSol™
  • Platforms
    • Obesity
    • Cardiotoxicity
    • Pulmonary Hypertension
    • Platforms' TRLs
  • Products & Services
    • Adipose Tissue
    • Services
  • About Us

Glauco R. Souza, Ph.D

Glauco R. Souza, PhD, Co-Founder, Director, former President and CSO of Nano3D Biosciences, and now Director of Global Business Development and Innovation at Greiner Bio-one (GBO). The inventor or co-inventor of all eleven patents related to magnetic 3D cell culture, Glauco is a major influence in the field of 3D cell culture. After GBO IP acquisition, Dr. Souza took the position at GBO to oversee 3D cell culture operations and marketing globally. He is instrumental in any needed product and technical support to be provided by GBO.


He is a former Adjunct Assistant Professor at the University of Texas Health Science Center at Houston. His work in 3D cell culture was selected for the Short List of the 2017 Lush Prize for outstanding research in producing an effective non-animal safety test Prior to co-founding Nano3D BioSciences, he was an Odyssey Scholar at The University of Texas M. D. Anderson Cancer Center. Glauco R. Souza has a B.S. in Chemistry, and M.S. and Ph.D. in Physical Chemistry from The George Washington University.

Connect with Glauco

Copyright © 2025 Bonds Biosystems Corporation - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept